Clinical Trial: International Extranodal NK/T-cell Lymphoma Project
Study Status: Completed
Recruit Status: Completed
Study Type: Observational
Official Title: International Extranodal NK/T-cell Lymphoma Project: Prognostic Factors in the Era of Nonanthracycline-based Treatment
Brief Summary: This study is to explore risk factors for poor progression-free survival (PFS) and overall survival (OS) in ENKTL, and establish a prognostic model for ENKTL patients treated with non-anthracycline based treatment.
Detailed Summary: This is a retrospective cohort study using anonymized information from patients with ENKTL. The following criteria are required: (1) Patients diagnosed with ENKTL, nasal type between January 1, 1995 and December 31, 2014; (2) Patients treated with non-anthracycline based therapy as an initial treatment. The pathology of initial diagnosis was reviewed by designated pathologists.
Sponsor: Samsung Medical Center
Current Primary Outcome: Overall survival [ Time Frame: 5 year ]
Original Primary Outcome: Overall survival [ Time Frame: Month ]
Current Secondary Outcome: Progression-free survival [ Time Frame: 5 year ]
Original Secondary Outcome: Progression-free survival [ Time Frame: Month ]
Information By: Samsung Medical Center
Dates:
Date Received: March 6, 2015
Date Started: January 2013
Date Completion:
Last Updated: April 8, 2017
Last Verified: April 2017